MBS496 - How to beat cancer with T cell therapeutics - Paul Lammas, CEO Triumvira.com (Built in Texas #1)

Send us a text

Triumvera is a clinical-stage immuno-oncology company, anchored in a deep understanding of T cell biology. Triumvira is developing unique, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat a broad range of patients with cancer.

Our company is backed by a strong intellectual property portfolio and a management team with deep experience in cell therapy, oncology drug development and manufacturing. By accessing the latest industry technologies, we are pursuing highly innovative autologous and allogeneic approaches for our TAC-based programs.

Get interviewed on the Matt Brown Show: www.mattbrownshow.com

Support the show